<DOC>
	<DOCNO>NCT02065271</DOCNO>
	<brief_summary>Rationale : The incidence obesity type 2 diabetes ( T2D ) increase rapidly account considerable part health care cost . Herbal supplement use many culture prevention treatment many different condition . Due lack scientific proof , application western culture minimal . Animal study show many constituent herbal supplement may beneficial effect several important parameter know affected T2D . Still , scientific proof human available . We therefore aim investigate effect 4-week herbal supplementation glucose metabolism , lipid metabolism , vascular function inflammation subject increase fast glucose level decrease glucose tolerance . Objective : The primary objective investigate 4-week herbal supplementation subject increase fast glucose level decrease glucose tolerance positive effect blood glucose level glucose tolerance . The secondary objective investigate 4-week herbal supplementation subject increase fast glucose level decrease glucose tolerance positive effect triglyceride ( TG ) , total cholesterol ( TC ) , low density lipoprotein ( LDL ) , high density lipoprotein ( HDL ) level , inflammation , adipose tissue white blood cell gene-expression AIX fast OGTT test . Study design : This study randomize , double-blind , placebo control cross-over trial two different treatment evaluate e.g . intervention herbal mixture placebo . Each person obtain treatment random order four week wash period four week in-between . Fasting blood sample collect subject receive OGTT , parallel PWA 4-week supplementation . Furthermore , 4-week supplement intake collect urine sample collect adipose tissue biopsy . The whole trial last three month . Study population : 26 overweight male females 50-75yrs old increase fasting glucose impair glucose tolerance . Intervention : Two intervention period 4-weeks participant take three time day supplement 500mg herbal placebo . Main study parameters/endpoints : Fasting blood glucose level , glucose tolerance determine oral glucose tolerance test ( OGTT ) , AIX , triglyceride ( TG ) , total cholesterol ( TC ) , low density lipoprotein ( LDL ) , high density lipoprotein ( HDL ) level , PWA , adipose tissue white blood cell gene expression marker inflammation . Nature extent burden risk associate participation , benefit group relatedness : Subjects participate study invest total 16.5 hour . Blood collection vena punctures/insertion venflon collection adipose tissue biopsy occasionally cause local hematoma bruise participant may report pain discomfort . The herbal supplement contain small amount St. John 's wort , may affect function liver enzymes . We therefore monitor liver function parameter supplementation period . Furthermore , subject exclude use medication know affected St. John 's wort . Participant donate 284ml blood , disperse 12 week .</brief_summary>
	<brief_title>Herbal Preparation Glucose Homeostasis</brief_title>
	<detailed_description />
	<mesh_term>Inflammation</mesh_term>
	<criteria>Males postmenopausal female For female : menstrual cycle absent 1 year age 5070yrs BMI &gt; 27 kg/m2 Increased fast glucose impair glucose tolerance ( twohour glucose level &gt; 7.8 mmol/L 75g oral glucose tolerance test fast glucose &gt; 6.1mmol/L ) . Systolic blood pressure &gt; 160mmHg diastolic blood pressure &gt; 100mmHg Tobacco smoker Received inoculation within 2 month start study plan study Donated intend donate blood 2 month study till month study . Unstable body weight ( weight gain loss &gt; 5kg past three month ) Diagnosed longterm medical condition ( e.g. , diabetes , haemophilia , CVD , anemia , gastrointestinal disease , renal failure , thyroid disorder , cancer , HIV , hepatitis C ) The use follow medicine : medicine interfere St Johns Worth , inhibitor immune system ( ciclosporine , tacrolimus , everolimus , temsirolimus sirolimus ) , coumarine type anticoagulant medicine ( acenocoumarol fenprocoumon ) , antiepileptica ( fenobarbital fenyto√Øne ) , theophylline , atorvastatine , simvastatine , digoxine , kinidine , voriconazol , proton pump inhibitor ( omeprazole esomeprazole ) antidepressives ( incl . MAO inhibitor SSRI 's ) . Abuse drugs/alcohol If participant n't want sign inform consent If participant n't want inform unexpected finding screen study Participation another biomedical study Additional exclusion criterion female : Current use contraceptive contain hormone Current use hormone replacement therapy</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>February 2014</verification_date>
</DOC>